Cortical Interneuron Degeneration In Alzheimer'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Cortical interneurons, particularly parvalbumin (PV)-positive and somatostatin (SST)-positive subtypes, show early vulnerability in Alzheimer's disease. This degeneration contributes to network dysfunction, epileptiform activity, and cognitive decline.
| Taxonomy |
ID |
Name / Label |
| Cell Ontology (CL) |
CL:0000099 |
interneuron |
- Morphology: interneuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
- Location: Primarily in layers 2/3 and 4
- Morphology: Basket cells and Chandelier cells
- Function: Fast-spiking, feedforward/feedback inhibition
- Markers: PV, GAD65/67, vGAT
- Location: Predominantly in layers 2-6
- Morphology: Martinotti cells
- Function: Dendritic inhibition, attention
- Markers: SST, NPY, GAD
- PV Neurons: Reduced density in MCI
- SST Neurons: Dendritic simplification
- VIP Neurons: Relatively preserved early
- Metabolic Stress: High energy demands (mitochondrial dysfunction)
- Oxidative Damage: Susceptibility to ROS
- Calcium Dysregulation: Impaired calcium homeostasis
- Amyloid Toxicity: Direct effects of Aβ
- Tau Pathology: Intracellular tau aggregates
- Inhibition Deficit: Reduced GABA release
- Network Hyperexcitability: Seizure susceptibility (epilepsy)
- Gamma Oscillation Impairment: Learning/memory deficits
- Information Processing: Altered cortical dynamics
- Postmortem tissue shows 30-50% PV neuron loss
- SST neurons show morphological changes
- Correlation with cognitive scores
- 5xFAD mice show interneuron vulnerability
- Tau models demonstrate interneuron dysfunction
- Rescue attempts with GABAergic drugs
The study of Cortical Interneuron Degeneration In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] DOI:10.1038/s41582-019-0216-y - Interneurons in AD
[2] DOI:10.1016/j.neuron.2020.08.001 - PV neurons and memory
[3] DOI:10.1002/alz.202000345 - SST neurons in AD progression